Asterios I. Karagiannis - Publications

Effects of Long-Term Use of Sodium-Glucose Co-Transporter-2 Inhibitors on Proteinuria and Renal Function in Patients with Type 2 Diabetes Mellitus without Chronic Kidney Disease during the COVID-19 Pandemic.

Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Published: December 23, 2025

The Associations between Kidney Function and Sexual Dysfunction among Males and Females with Type 2 Diabetes Mellitus.

Journal: Medicina (Kaunas, Lithuania)

Published: April 19, 2023

The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study.

Journal: Clinical rheumatology

Published: August 18, 2022

Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study.

Journal: Medicina (Kaunas, Lithuania)

Published: July 19, 2022

Effect of sodium-glucose co-transporter-2 inhibitors on arterial stiffness: A systematic review and meta-analysis of randomized controlled trials.

Journal: Vascular medicine (London, England)

Published: June 27, 2022

Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia.

Journal: The American journal of cardiology

Published: May 17, 2022

Effect of sodium-glucose co-transporter-2 inhibitors on right ventricular function in patients with type 2 diabetes mellitus: A pilot study.

Journal: Kardiologia polska

Published: April 20, 2022

Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle.

Journal: The international journal of cardiovascular imaging

Published: April 07, 2022

Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease.

Journal: The American journal of cardiology

Published: April 01, 2022

Meta-Analysis Assessing the Impact of Previous Heart Failure and Chronic Kidney Disease on the Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor Agonists.

Journal: The American journal of cardiology

Published: December 09, 2021

"Which one should I choose, a glucagon-like peptide-1 receptor agonist or a sodium-glucose cotransporter 2 inhibitor? Or maybe both?"

Journal: European journal of internal medicine

Published: November 29, 2021

Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study.

Journal: Archives of medical sciences. Atherosclerotic diseases

Published: November 22, 2021